Cartesian Therapeutics 1 article

The cell-therapy profile of Cartesian Therapeutics includes mRNA cell therapy, while autologous mRNA CAR-T cells supplies a more specific engineering or disease context. Its cell-therapy architecture extends from autoimmune disease cell therapy to generalized myasthenia gravis therapy, with antisynthetase syndrome cell therapy shaping potency, persistence, targeting or immune compatibility. Specific cell types, genetic modifications and therapeutic products remain distinct tags; the cellular strategy of Cartesian Therapeutics also includes BCMA-directed plasma cell targeting.